Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost PK/Tolerability in Male AGA
NCT02848300Phase 1Completed
- Sponsor
- Allergan
- Start
- Jul 2016
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, single-arm trial of bimatoprost in androgenetic alopecia (AGA), sponsored by Allergan. Primary endpoints: Drug Concentration in Skin Biopsy Samples at Day 14 and Percentage of Participants with at Least 1 Treatment Emergent Adverse Event at 28 Days. Started Jul 2016; status: completed.
02
Drugs
bimatoprost
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT02848300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02848300.